Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Pharmacogenomic Testing × Clear all

NCT01015833 2022-08-04

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Phase 3 Completed

356 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01324076 2011-05-13

Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms